Multiple immuno-regulatory defects in type-1 diabetes

Abstract

Susceptibility to immune-mediated diabetes (IMD) in humans and NOD mice involves their inherently defective T cell immunoregulatory abilities.We have followed natural killer (NK) T cell numbers in patients with IMD, both by flow cytometry using mAbs to the characteristic junctions found in the T cell receptors of this cell subtype, and by semiquantitative RT-PCR for the corresponding transcripts.Both before and after clinical onset, the representation of these cells in patients' PBMCs is reduced.We also report low numbers of resting CD4 + CD25 + T cells in IMD patients, a subset of T cells shown to have important immunoregulatory functions in abrogating autoimmunities in 3-day thymectomized experimental mice.Whereas a biased Th1 to Th2 cytokine profile has been suggested to underlie the pathogenesis of IMD in both species, we found defective production of IFN- in our patients after in vitro stimulation of their PBMCs by phorbol-myristate acetate and ionomycin and both IFN- and IL-4 deficiencies in V24 + NK T-enriched cells.These data suggest that multiple immunoregulatory T (Treg) cell defects underlie islet cell autoimmunity leading to IMD in humans and that these lesions may be part of a broad T cell defect.